Your browser doesn't support javascript.
loading
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS).
Kirk, Ben; Cawthon, Peggy M; Arai, Hidenori; Ávila-Funes, José A; Barazzoni, Rocco; Bhasin, Shalender; Binder, Ellen F; Bruyere, Olivier; Cederholm, Tommy; Chen, Liang-Kung; Cooper, Cyrus; Duque, Gustavo; Fielding, Roger A; Guralnik, Jack; Kiel, Douglas P; Landi, Francesco; Reginster, Jean-Yves; Sayer, Avan A; Visser, Marjolein; von Haehling, Stephan; Woo, Jean; Cruz-Jentoft, Alfonso J.
Afiliación
  • Kirk B; Department of Medicine, Western Health, Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia.
  • Cawthon PM; Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, Melbourne, VIC, Australia.
  • Arai H; California Pacific Medical Center, Research Institute, 550 16th Street, Second Floor, San Francisco, CA 94143USA.
  • Ávila-Funes JA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CAUSA.
  • Barazzoni R; National Center for Geriatrics and Gerontology, Obu, AichiJapan.
  • Bhasin S; Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Binder EF; Bordeaux Population Health Research Center, UMR 1219, University of Bordeaux, Inserm, Bordeaux F-33000, France.
  • Bruyere O; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Cederholm T; Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MAUSA.
  • Chen LK; Division of General Medicine and Geriatrics, School of Medicine, Washington University in St. Louis, St. Louis MO, USA.
  • Cooper C; WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
  • Duque G; Department of Sport and Rehabilitation Sciences, University of Liège, Liège, Belgium.
  • Fielding RA; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
  • Guralnik J; Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.
  • Kiel DP; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Landi F; Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Reginster JY; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
  • Sayer AA; Department of Epidemiology, University of Oxford, Oxford, OXUK.
  • Visser M; Bone, Muscle & Geroscience Group, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • von Haehling S; Dr Joseph Kaufmann Chair in Geriatric Medicine, Department of Medicine, McGill University, Montreal, QC, Canada.
  • Woo J; Nutrition Exercise, Physiology, and Sarcopenia Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MAUSA.
  • Cruz-Jentoft AJ; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MDUSA.
Age Ageing ; 53(3)2024 03 01.
Article en En | MEDLINE | ID: mdl-38520141
ABSTRACT
IMPORTANCE Sarcopenia, the age-related loss of muscle mass and strength/function, is an important clinical condition. However, no international consensus on the definition exists.

OBJECTIVE:

The Global Leadership Initiative in Sarcopenia (GLIS) aimed to address this by establishing the global conceptual definition of sarcopenia.

DESIGN:

The GLIS steering committee was formed in 2019-21 with representatives from all relevant scientific societies worldwide. During this time, the steering committee developed a set of statements on the topic and invited members from these societies to participate in a two-phase International Delphi Study. Between 2022 and 2023, participants ranked their agreement with a set of statements using an online survey tool (SurveyMonkey). Statements were categorised based on predefined thresholds strong agreement (>80%), moderate agreement (70-80%) and low agreement (<70%). Statements with strong agreement were accepted, statements with low agreement were rejected and those with moderate agreement were reintroduced until consensus was reached.

RESULTS:

107 participants (mean age 54 ± 12 years [1 missing age], 64% men) from 29 countries across 7 continents/regions completed the Delphi survey. Twenty statements were found to have a strong agreement. These included; 6 statements on 'general aspects of sarcopenia' (strongest agreement the prevalence of sarcopenia increases with age (98.3%)), 3 statements on 'components of sarcopenia' (muscle mass (89.4%), muscle strength (93.1%) and muscle-specific strength (80.8%) should all be a part of the conceptual definition of sarcopenia)) and 11 statements on 'outcomes of sarcopenia' (strongest agreement sarcopenia increases the risk of impaired physical performance (97.9%)). A key finding of the Delphi survey was that muscle mass, muscle strength and muscle-specific strength were all accepted as 'components of sarcopenia', whereas impaired physical performance was accepted as an 'outcome' rather than a 'component' of sarcopenia. CONCLUSION AND RELEVANCE The GLIS has created the first global conceptual definition of sarcopenia, which will now serve to develop an operational definition for clinical and research settings.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcopenia Límite: Aged / Female / Humans / Male Idioma: En Revista: Age Ageing Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcopenia Límite: Aged / Female / Humans / Male Idioma: En Revista: Age Ageing Año: 2024 Tipo del documento: Article País de afiliación: Australia